Sequential Medicine Ltd Report issue

For profit Phase 3
Founded: George Town Cayman Islands (2017)
Status: No NME R&D (2017)

Organization Overview

First Clinical Trial
2017
NCT03331042
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Sequential Medicine Ltd

Active Ingredients

Drugs in Phase 3 Trials (3)

diphenhydramine (benadryl) (3 trials)

lorazepam (ativan) (2 trials)

zolpidem (ambien) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Sleep Initiation and Maintenance Disorders (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 3